| # | Company | Symbol | Weight | Price | Chg | % Chg |
|---|---|---|---|---|---|---|
| 1 | Tempus Ai Inc | TEM | 9.28% | 71.56 |
-0.22 | (-0.31%) |
| 2 | Crispr Therapeutics Ag | CRSP | 8.65% | 55.21 |
0.63 | (1.15%) |
| 3 | Guardant Health Inc | GH | 5.88% | 97.71 |
-0.21 | (-0.21%) |
| 4 | Twist Bioscience Corp | TWST | 5.50% | 31.32 |
0.36 | (1.16%) |
| 5 | Personalis Inc | PSNL | 4.68% | 8.44 |
-0.19 | (-2.20%) |
| 6 | Recursion Pharmaceuticals-A | RXRX | 4.50% | 4.71 |
0.20 | (4.43%) |
| 7 | Natera Inc | NTRA | 4.39% | 206.72 |
0.09 | (0.04%) |
| 8 | 10x Genomics Inc-Class A | TXG | 4.29% | 16.59 |
-0.49 | (-2.87%) |
| 9 | Illumina Inc | ILMN | 4.09% | 122.60 |
0.88 | (0.72%) |
| 10 | Veracyte Inc | VCYT | 4.02% | 42.66 |
0.31 | (0.73%) |
| 11 | Beam Therapeutics Inc | BEAM | 4.02% | 22.48 |
0.83 | (3.83%) |
| 12 | Adaptive Biotechnologies | ADPT | 3.36% | 14.53 |
-0.18 | (-1.22%) |
| 13 | Absci Corp | ABSI | 3.31% | 3.45 |
0.13 | (3.92%) |
| 14 | Ionis Pharmaceuticals Inc | IONS | 3.12% | 72.45 |
2.91 | (4.18%) |
| 15 | Schrodinger Inc | SDGR | 2.90% | 18.30 |
0.01 | (0.05%) |
| 16 | Caredx Inc | CDNA | 2.85% | 16.78 |
0.08 | (0.48%) |
| 17 | Intellia Therapeutics Inc | NTLA | 2.62% | 10.18 |
0.45 | (4.62%) |
| 18 | Arcturus Therapeutics Holdin | ARCT | 1.82% | 0.00 |
0.00 | (0.00%) |
| 19 | Exact Sciences Corp | EXAS | 1.65% | 67.50 |
0.92 | (1.38%) |
| 20 | Pacific Biosciences of Calif | PACB | 1.64% | 1.86 |
0.10 | (5.68%) |
| 21 | Prime Medicine Inc | PRME | 1.63% | 3.92 |
0.40 | (11.21%) |
| 22 | Nurix Therapeutics Inc | NRIX | 1.61% | 12.86 |
0.61 | (4.98%) |
| 23 | Amgen Inc | AMGN | 1.31% | 338.45 |
14.79 | (4.57%) |
| 24 | 908 Devices Inc | MASS | 1.25% | 5.90 |
-0.50 | (-7.82%) |
| 25 | Genedx Holdings Corp | WGS | 1.24% | 139.91 |
-2.71 | (-1.90%) |
| 26 | Incyte Corp | INCY | 1.23% | 108.16 |
2.18 | (2.06%) |
| 27 | Atai Beckley Nv | ATAI | 1.23% | 4.43 |
0.08 | (1.84%) |
| 28 | Butterfly Network Inc | BFLY | 1.19% | 2.46 |
0.24 | (10.81%) |
| 29 | Veeva Systems Inc-Class A | VEEV | 1.03% | 299.10 |
3.35 | (1.13%) |
| 30 | Compass Pathways Plc | CMPS | 1.00% | 5.70 |
-0.04 | (-0.70%) |
| 31 | Cerus Corp | CERS | 0.98% | 1.65 |
0.05 | (3.12%) |
| 32 | Quantum-Si Inc | QSI | 0.95% | 1.58 |
-0.01 | (-0.94%) |
| 33 | Vertex Pharmaceuticals Inc | VRTX | 0.91% | 429.22 |
8.02 | (1.90%) |
| 34 | Caris Life Sciences Inc | CAI | 0.74% | 25.16 |
0.36 | (1.45%) |
| 35 | Regeneron Pharmaceuticals | REGN | 0.69% | 674.55 |
19.81 | (3.03%) |
| 36 | Standard Biotools Inc | LAB | 0.30% | 1.19 |
0.02 | (1.71%) |
| 37 | Goldman Fs Trsy Oblig Inst 468 | 0.12% | 0.00 |
0.00 | (0.00%) |
| ARKK | 82.05 |
-0.79 | (-0.95%) |
| ARKQ | 115.13 |
-1.34 | (-1.15%) |
| ARKW | 164.18 |
-2.91 | (-1.74%) |
| ARKG | 28.81 |
0.30 | (1.05%) |
| ARKF | 52.88 |
-0.46 | (-0.86%) |
| ARKX | 29.12 |
-0.14 | (-0.48%) |
| PRNT | 22.79 |
0.02 | (0.07%) |
| IZRL | 29.45 |
0.22 | (0.75%) |
The holdings for the ARK Genomic Revolution ETF are updated after each trading day. Exact holdings and weights are subject to change daily. There are currently 37 holdings in the fund.
Data as of 11/10/2025.